Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Title II—Medical Device User Fee Amendments of 2007 | Statement: [Food and Drug Administration Amendments Act of 2007, hasSection, Title II—Medical Device User Fee Amendments of 2007]

Target entity: Title II—Medical Device User Fee Amendments of 2007
Context triple: [Food and Drug Administration Amendments Act of 2007, hasSection, Title II—Medical Device User Fee Amendments of 2007]

• A. Medical Device Amendments of 1976
  The Medical Device Amendments of 1976 are U.S. legislation that established a comprehensive regulatory framework for the safety and effectiveness of medical devices, including classification, premarket approval, and performance standards.
• B. Food and Drug Administration Safety and Innovation Act of 2012
  The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
• C. Food and Drug Administration Amendments Act of 2007 chosen
  The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
• D. Food and Drug Administration Modernization Act of 1997
  The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
• E. Prescription Drug User Fee Act of 1992
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.